Professor at Shandong Second Medical University, China
Maotao He, M.D., Ph.D., is a distinguished Professor in the Department of Diagnostic Pathology at Shandong Second Medical University. With extensive expertise in pathology and pathophysiology, Dr. He’s research focuses on investigating the mechanisms, pathogenesis, and potential treatments for various neurological disorders, including stroke, traumatic brain injury, Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. He is known for his contributions to the field of neuroprotection and has a strong track record of publications in renowned scientific journals.
Author Metrics
Scopus Profile
Google Scholar Profile
Dr. Maotao He has a notable publication record, with several impactful articles in prestigious journals such as the International Journal of Biological Sciences, Translational Stroke Research, and Cell Mol Life Sci. His research has garnered attention within the scientific community, evident from citations and collaborations with other leading researchers in the field of neuroscience and pathology.
Maotao He’s Scopus Author Identifier profile. Based on the provided information, Maotao He has 128 citations from 122 documents, with an h-index of 6. This suggests that his research has been cited by other authors in the academic literature, and his work has had an impact in his field.
Maotao He has authored 11 documents indexed in Scopus, indicating his active contribution to academic publications. His research output reflects his engagement in scholarly activities and his commitment to advancing knowledge in his area of expertise.
Education
Dr. He obtained his Ph.D. in Pathology and Pathophysiology from Ningxia Medical University, following which he pursued a Master’s degree in the same field. He began his academic journey with a Bachelor’s degree in Clinical Medicine from Weifang Medical University. His educational background equipped him with the necessary knowledge and skills to embark on a successful career in research and academia.
Research Focus
Dr. He’s research primarily revolves around exploring the intricate mechanisms underlying various brain diseases, with a particular emphasis on neuroprotection. He is dedicated to identifying novel therapeutic agents and interventions to mitigate the devastating effects of neurological disorders. His research spans from understanding molecular pathways to preclinical evaluations of potential treatments.
Professional Journey
Throughout his career, Dr. He has held significant positions in academia and research. He has served as a Research Scientist at the Department of Pharmaceutical Sciences at North Carolina Central University and currently holds the position of Professor at Weifang Medical University. His professional journey reflects his commitment to advancing scientific knowledge and translating research findings into clinical applications.
Honors & Awards
Dr. He has received recognition for his outstanding contributions to the field of neuroscience and pathology. His research has been funded by prestigious organizations such as the National Natural Science Foundation of China and the National Institutes of Health. Additionally, he has presented his work at various conferences and symposiums, earning accolades for his contributions to scientific knowledge.
Publications Noted & Contributions
Dr. He has authored numerous publications that have significantly contributed to the understanding of neuroprotection and brain diseases. His research has shed light on critical pathways involved in ischemic damage, mitochondrial dysfunction, and neuroinflammation. His findings have implications for the development of novel therapeutic strategies for neurological disorders.
Title: “Lycium Barbarum polysaccharides ameliorates hyperglycemia-exacerbated cerebral ischemia/reperfusion injury via protecting blood-brain barrier”
- Journal: Transplant Immunology
- Year: 2023
- Volume: 76
- Pages: 101757
- Authors: Q. Zhao, YM Jing, MT He, L. Jing, YF Xi, JZ Zhang
Title: “A plant-based mutant huntingtin model-driven discovery of impaired expression of GTPCH and DHFR”
- Journal: Cellular and Molecular Life Sciences
- Year: 2022
- Volume: 79
- Issue: 11
- Pages: 553
- Authors: CY Hung, C. Zhu, FS Kittur, M. He, E. Arning, J. Zhang, AJ Johnson, and others
Title: “Therapeutic strategies targeting the NLRP3‑mediated inflammatory response and pyroptosis in cerebral ischemia/reperfusion injury”
- Journal: Molecular Medicine Reports
- Year: 2024
- Volume: 29
- Issue: 3
- Pages: 1-11
- Authors: WL Duan, XJ Wang, YP Ma, ZM Sheng, H Dong, LY Zhang, BG Zhang, and others
Title: “Mutant huntingtin exon-1 impaired GTPCH and DHFR expression in plants and mice”
- Journal: bioRxiv
- Year: 2022
- Pages: 2022.05.18.492514
- Authors: CY Hung, C. Zhu, FS Kittur, M. He, E. Arning, J. Zhang, AJ Johnson, and others
Title: “Oxymatrine Induces Autophagy and Apoptosis in Human Poorly Differentiated Gastric Adenocarcinoma Cells via Slit2/Robo1 Signals”
- Journal: medRxiv
- Year: 2021
- Pages: 2021.04.28.21256231
- Authors: MT He, T. Zhang, J. Hei, L. Ma
Title: “EVALUATION OF NEUROPROTECTIVE FUNCTION OF PLANT-PRODUCED ERYTHROPOIETIN DERIVATIVE IN ISCHEMIA/REPERFUSION BRAIN INJURY MOUSE MODEL”
- Journal: INTERNATIONAL JOURNAL OF STROKE
- Year: 2020
- Volume: 15
- Issue: 1_ SUPPL
- Pages: 140-140
- Authors: M He, F Kittur, CY Hung, J Zhang, P Li, J Xie
Research Timeline
Dr. He’s research timeline spans several years, during which he has made significant progress in understanding the pathogenesis and treatment of brain diseases. From his early investigations into mitochondrial damage in cerebral ischemia to his recent studies on neuroprotective agents, his research trajectory reflects a continuous commitment to advancing knowledge in the field of neuroscience.
Collaborations and Projects
Dr. He has collaborated with various researchers and institutions globally to further his research goals. His involvement in collaborative projects, both nationally and internationally, has facilitated the exchange of ideas and expertise, leading to innovative approaches in neuroprotection research. His ongoing projects focus on identifying new therapeutic targets and evaluating their efficacy in preclinical models of neurological disorders.
Significance of Contribution
Maotao He’s research has made significant contributions to the field of neuroscience and pathology by addressing critical issues related to the pathogenesis and treatment of brain diseases. His investigations into the mechanisms underlying stroke, traumatic brain injury, Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease have provided valuable insights into the complex nature of these disorders. By elucidating key molecular pathways and identifying potential therapeutic targets, his work has paved the way for the development of novel treatments and interventions aimed at improving patient outcomes and quality of life. Through his research, Maotao He has played a pivotal role in advancing scientific knowledge and addressing unmet clinical needs in neurology and neuropathology.
Originality and Innovation
Maotao He’s research exhibits a high degree of originality and innovation, characterized by novel approaches and groundbreaking discoveries. His studies on neuroprotection have challenged conventional paradigms and introduced innovative concepts that have reshaped our understanding of brain diseases. From the development of plant-produced neuroprotective agents to the identification of novel molecular targets, his work demonstrates a commitment to pushing the boundaries of scientific inquiry. By combining cutting-edge methodologies with creative thinking, Maotao He has been able to uncover new insights into the pathophysiology of neurological disorders and propose innovative strategies for their treatment. His innovative contributions have garnered attention within the scientific community and have the potential to revolutionize the field of neurology and neuropathology.
